Clinical trial
Use of the Paradigm 722 System to Improve Glycemic Control in Adult and…
NCT00211510 · Medtronic Diabetes, Industry · Completed
Key facts
| NCT number | NCT00211510 |
|---|---|
| Title | Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes |
| Official title | Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes: A Multi-center, Randomized Controlled Trial |
| Acronym | STAR1 |
| Lead sponsor | Medtronic Diabetes, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Device |
| Interventions | Paradigm 722 sensor augmented pump, Paradigm 715 insulin pump |
| Enrollment | 146 |
| Start date | Jun 1, 2005 |
| Primary completion | Aug 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Jun 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: